Don't Abolish Tenure; But Make It Conditional

Before the end of this year, the British government will have compelled the country’s universities to curtail the time-honored system of offering tenured employment to their staff (The Scientist, June 27, page 21). The Thatcher administration, whose massive parliamentary majority makes this step inevitable, believes that “jobs for life” can no longer be justified. The universities and many opposition politicians, especially those in the House of Lords, have strongly conteste

Written byAlexander Kohn
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Before the end of this year, the British government will have compelled the country’s universities to curtail the time-honored system of offering tenured employment to their staff (The Scientist, June 27, page 21). The Thatcher administration, whose massive parliamentary majority makes this step inevitable, believes that “jobs for life” can no longer be justified. The universities and many opposition politicians, especially those in the House of Lords, have strongly contested the move as a threat to intellectual freedom.

It is an important question, with implications for many other countries. As I see it, however, the issue is by no means as black and white as it has been painted in Britain. Consider first the age at which scientists can be offered security of employment until retirement. Throughout the world, this tends to happen at about 40, when individuals become candidates for associate professorships (or positions of equivalent rank in research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies